Evidence map›Paper›PMID 31655458›Full record

ArticleCytokine2020

The elevated systemic cytokine levels in HIV patients are not associated with an elevated pulmonary cytokine environment.

Rafael Fernandez-Botran, Andrea Reyes Vega, Yasmany García, Chanakya Charan Tirumala, Praneet Srisailam, Anupama Raghuram, Paula Peyrani, Stephen Furmanek, Mahder Alem Tella, Jeffrey D Ritzhentaler and 2 more

Open access · greenAbstract read
In one paragraph

Article in Cytokine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Rafael Fernandez-BotranDepartment of Pathology & Laboratory Medicine, University of Louisville Health Sciences Center, Louisville, KY 40202, United States. Electronic address: grfern01@louisville.edu.
Andrea Reyes VegaDepartment of Medicine, Division of Infectious Diseases, University of Louisville Health Sciences Center, Louisville, KY 40202, United States.
Yasmany GarcíaDepartment of Medicine, Division of Infectious Diseases, University of Louisville Health Sciences Center, Louisville, KY 40202, United States.
Chanakya Charan TirumalaDepartment of Medicine, Division of Infectious Diseases, University of Louisville Health Sciences Center, Louisville, KY 40202, United States.
Praneet SrisailamDepartment of Medicine, Division of Infectious Diseases, University of Louisville Health Sciences Center, Louisville, KY 40202, United States.
Anupama RaghuramDepartment of Medicine, Division of Infectious Diseases, University of Louisville Health Sciences Center, Louisville, KY 40202, United States.
Paula PeyraniDepartment of Medicine, Division of Infectious Diseases, University of Louisville Health Sciences Center, Louisville, KY 40202, United States.
Stephen FurmanekDepartment of Medicine, Division of Infectious Diseases, University of Louisville Health Sciences Center, Louisville, KY 40202, United States.
Mahder Alem TellaDepartment of Medicine, Division of Infectious Diseases, University of Louisville Health Sciences Center, Louisville, KY 40202, United States.
Jeffrey D RitzhentalerDepartment of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Louisville Health Sciences Center, Louisville, KY 40202, United States; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care and the Jane & Leonard Korman Respiratory Institute, Thomas Jefferson University, Philadelphia, PA, United States(1).
Jesse RomanDepartment of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Louisville Health Sciences Center, Louisville, KY 40202, United States; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care and the Jane & Leonard Korman Respiratory Institute, Thomas Jefferson University, Philadelphia, PA, United States(1).
Julio A RamírezDepartment of Medicine, Division of Infectious Diseases, University of Louisville Health Sciences Center, Louisville, KY 40202, United States.
University of Louisville · US

Funding

The Impact of Oxidative Stress on HIV-induced Lung DiseaseU01HL121807 · NHLBI · UNIVERSITY OF LOUISVILLE · PI RAMIREZ, JULIO ALBERTO, ROMAN, JESSE · 2013 to 2017
$2.7M
NHLBI NIH HHS U01 HL121807
6 · The paper itself

Abstract

backgroundHIV-positive patients on anti-retroviral therapy (ART) are at higher risk of developing many non-AIDS related chronic diseases, including chronic obstructive pulmonary disease (COPD), compared to HIV-negative individuals. While the mechanisms are not clear, a persistent pro-inflammatory state appears to be a key contributing factor. The aims of this study were to investigate whether HIV-positive patients without COPD present evidence of potentially predisposing abnormal pulmonary cytokine/chemokine environment and to explore the relationship between pulmonary and systemic cytokine levels.

methodsThis study included 39 HIV-seropositive and 34 HIV-seronegative subjects without COPD. All were subjected to outpatient bronchoscopy with bronchoalveolar lavage fluid (BALF) aspiration and blood sample collection. The levels of 21 cytokines and chemokines were measured in plasma and BALF using a bead-based multi-analyte assay.

resultsIn plasma, HIV-infected patients showed significantly increased circulating levels of pro-inflammatory (TNFα) and Th1-associated cytokines (IL-12p70) as well as several chemokines (CXCL11 and CX3CL1). However, no statistically significant differences were found in the numbers of cells, the concentrations of protein and urea as well as cytokine levels in the BALFs of HIV-positive patients when compared to controls. Correlation analysis indicated a potential modulatory effect of the BMI in HIV-seropositive individuals.

conclusionsWhile our results are consistent with the existence of a systemic pro-inflammatory state in HIV-infected patients, they did not detect significant differences in cytokine levels and other inflammatory markers in the lungs of HIV-positive individuals when compared to HIV-negative controls.

Indexed as

Bronchoalveolar Lavage FluidAdultChemokine CX3CL1Chemokine CXCL11ChemokinesCross-Sectional StudiesCytokinesFemaleHIV InfectionsHumansInflammationInterleukin-12LungMaleMiddle AgedTumor Necrosis Factor-alphaChemokine CX3CL1Chemokine CXCL11ChemokinesCX3CL1 protein, humanCXCL11 protein, humanCytokinesInterleukin-12Tumor Necrosis Factor-alphaChemokinesChronic lung disease (CLD)CytokinesHIVInflammation

Identifiers

PMID31655458
PMCPMC6938540
OpenAlexW2981987254

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.